ArticleFertility and sterility2017
Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women.
Article in Fertility and sterility, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 53 citations in OpenAlex.
- Incident endometriosis diagnosis and AMH: how surgical staging and typology relate to serum AMH levels.American journal of obstetrics and gynecology · 2026Article
- The effects of intrauterine devices on anti-Mullerian hormone levels-a mini-review.Gynecology and pelvic medicine · 2026Review
- Age at menarche and risk of ovarian hyperstimulation syndrome in women undergoing IVF/ICSI cycles: a retrospective cohort study.BMJ open · 2024Article
- Associations of reproductive and breastfeeding history with anti-Müllerian hormone concentration among African-American women of reproductive age.Reproductive biomedicine online · 2023Article
- High physical activity and ovarian reserve: a prospective study of normo-ovulatory professional athletes.Journal of ovarian research · 2022Observational
- Correlation of serum anti-Mullerian hormone with hormonal and environmental parameters in Brazilian climacteric women.Scientific reports · 2022Article
- The association of parity and breastfeeding with anti-Müllerian hormone levels at two time points.Maturitas · 2022Observational
- Article
- Association between cigarette smoking and ovarian reserve among women seeking fertility care.PloS one · 2022Article
- Breast Cancer Risk Factors and Circulating Anti-Müllerian Hormone Concentration in Healthy Premenopausal Women.The Journal of clinical endocrinology and metabolism · 2021Article
- The association between the levels of anti-Müllerian hormone (AMH) and dietary intake in Iranian women.Archives of gynecology and obstetrics · 2021Article
- Longitudinal changes in reproductive hormones through the menopause transition in the Avon Longitudinal Study of Parents and Children (ALSPAC).Scientific reports · 2020Article
- Antimüllerian hormone and F2-isoprostanes in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.Fertility and sterility · 2020Article
- Smoke, alcohol and drug addiction and female fertility.Reproductive biology and endocrinology : RB&E · 2020Review
- Association between a history of depression and anti-müllerian hormone among late-reproductive aged women: the Harvard study of moods and cycles.Women's midlife health · 2020Article
- Anti-Müllerian hormone levels in nurses working night shifts.Archives of environmental & occupational health · 2020Article
- Ethnicity/Race and Age-Specific Variations of Serum AMH in Women-A Review.Frontiers in endocrinology · 2020Review
- Do dietary intakes influence the rate of decline in anti-Mullerian hormone among eumenorrheic women? A population-based prospective investigation.Nutrition journal · 2019Article
- Ovarian Reserve Testing: A Review of the Options, Their Applications, and Their Limitations.Clinical obstetrics and gynecology · 2019Review
- Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model.Breast cancer research : BCR · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors at 20 institutions in 13 countries.
Funding
Abstract
objectiveTo identify reproductive, lifestyle, hormonal, and other correlates of circulating antimüllerian hormone (AMH) concentrations in mostly late premenopausal women.
designCross-sectional study.
settingNot applicable. PATIENT(S): A total of 671 premenopausal women not known to have cancer. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Concentrations of AMH were measured in a single laboratory using the picoAMH ELISA. Multivariable-adjusted median (and interquartile range) AMH concentrations were calculated using quantile regression for several potential correlates. RESULT(S): Older women had significantly lower AMH concentrations (≥40 [n = 444] vs. <35 years [n = 64], multivariable-adjusted median 0.73 ng/mL vs. 2.52 ng/mL). Concentrations of AMH were also significantly lower among women with earlier age at menarche (<12 [n = 96] vs. ≥14 years [n = 200]: 0.90 ng/mL vs. 1.12 ng/mL) and among current users of oral contraceptives (n = 27) compared with never or former users (n = 468) (0.36 ng/mL vs. 1.15 ng/mL). Race, body mass index, education, height, smoking status, parity, and menstrual cycle phase were not significantly associated with AMH concentrations. There were no significant associations between AMH concentrations and androgen or sex hormone-binding globulin concentrations or with factors related to blood collection (e.g., sample type, time, season, and year of blood collection). CONCLUSION(S): Among premenopausal women, lower AMH concentrations are associated with older age, a younger age at menarche, and currently using oral contraceptives, suggesting these factors are related to a lower number or decreased secretory activity of ovarian follicles.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.